Search Results for: OGT

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
CXADR CXADR cell adhesion molecule
  • Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
  • Cell surface interactions at the vascular wall
DAPK3 death associated protein kinase 3
  • Caspase activation via Dependence Receptors in the absence of ligand
  • 2-tert-butyl-9-fluoro-1,6-dihydrobenzo[h]imidazo[4,5-f]isoquinolin-7-one
  • 4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2-b]pyridazin-3-yl)benzoic acid
  • (4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile
  • Fostamatinib
DAZAP1 DAZ associated protein 1
DBN1 drebrin 1
  • RHOD GTPase cycle
  • RHOH GTPase cycle
  • RHOBTB2 GTPase cycle
  • RHOBTB1 GTPase cycle
DBNL drebrin like
  • Caspase-mediated cleavage of cytoskeletal proteins
  • Neurexins and neuroligins
  • Neutrophil degranulation
DBT dihydrolipoamide branched chain transacylase E2
  • Branched-chain amino acid catabolism
  • RHOH GTPase cycle
  • Mitochondrial protein degradation
  • Protein lipoylation
  • BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV
  • Loss-of-function mutations in DBT cause MSUD2
  • Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD
  • Loss-of-function mutations in DLD cause MSUD3/DLDD
  • Branched-chain ketoacid dehydrogenase kinase deficiency
  • H139Hfs13* PPM1K causes a mild variant of MSUD
  • Maple syrup urine disease (MSUD)
DCTN2 dynactin subunit 2
  • MHC class II antigen presentation
  • Regulation of PLK1 Activity at G2/M Transition
  • HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand
  • Loss of Nlp from mitotic centrosomes
  • Recruitment of mitotic centrosome proteins and complexes
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Recruitment of NuMA to mitotic centrosomes
  • Anchoring of the basal body to the plasma membrane
  • COPI-mediated anterograde transport
  • COPI-independent Golgi-to-ER retrograde traffic
  • AURKA Activation by TPX2
DDX17 DEAD-box helicase 17
  • SUMOylation of transcription cofactors
DDX28 DEAD-box helicase 28
DDX39B DExD-box helicase 39B
  • Transport of Mature mRNA derived from an Intron-Containing Transcript
  • mRNA Splicing - Major Pathway
  • mRNA 3'-end processing
  • RNA Polymerase II Transcription Termination
  • RHOBTB2 GTPase cycle
  • Artenimol
DDX3X DEAD-box helicase 3 X-linked
  • Neutrophil degranulation
DDX41 DEAD-box helicase 41
  • STING mediated induction of host immune responses
  • Regulation of innate immune responses to cytosolic DNA
  • IRF3-mediated induction of type I IFN
  • mRNA Splicing - Major Pathway
DDX47 DEAD-box helicase 47
  • rRNA modification in the nucleus and cytosol
  • Major pathway of rRNA processing in the nucleolus and cytosol
DDX5 DEAD-box helicase 5
  • SUMOylation of transcription cofactors
  • mRNA Splicing - Major Pathway
  • Estrogen-dependent gene expression
  • Replication of the SARS-CoV-1 genome
  • Replication of the SARS-CoV-2 genome
  • Artenimol
  • Prostate cancer
DDX56 DEAD-box helicase 56
DEK DEK proto-oncogene
  • B-WICH complex positively regulates rRNA expression
  • Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors
  • Transcriptional regulation of granulopoiesis
  • Transcriptional regulation of granulopoiesis
DHX30 DExH-box helicase 30
DHX9 DExH-box helicase 9
  • RIP-mediated NFkB activation via ZBP1
  • DEx/H-box helicases activate type I IFN and inflammatory cytokines production
  • mRNA Splicing - Major Pathway
  • PKR-mediated signaling
DLD dihydrolipoamide dehydrogenase
  • Regulation of pyruvate dehydrogenase (PDH) complex
  • Signaling by Retinoic Acid
  • Glycine degradation
  • Branched-chain amino acid catabolism
  • Mitochondrial protein degradation
  • OGDH complex synthesizes succinyl-CoA from 2-OG
  • OADH complex synthesizes glutaryl-CoA from 2-OA
  • BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV
  • PDH complex synthesizes acetyl-CoA from PYR
  • Loss-of-function mutations in DBT cause MSUD2
  • Loss-of-function mutations in DLD cause MSUD3/DLDD
  • Branched-chain ketoacid dehydrogenase kinase deficiency
  • H139Hfs13* PPM1K causes a mild variant of MSUD
  • NADH
  • Flavin adenine dinucleotide
  • Pyruvate dehydrogenase complex deficiency; X-linked Leigh syndrome
  • Maple syrup urine disease (MSUD)
DLG3 discs large MAGUK scaffold protein 3
  • Unblocking of NMDA receptors, glutamate binding and activation
  • Unblocking of NMDA receptors, glutamate binding and activation
  • Ras activation upon Ca2+ influx through NMDA receptor
  • NrCAM interactions
  • Activation of Ca-permeable Kainate Receptor
  • RAF/MAP kinase cascade
  • Neurexins and neuroligins
  • Neurexins and neuroligins
  • Synaptic adhesion-like molecules
  • Assembly and cell surface presentation of NMDA receptors
  • Negative regulation of NMDA receptor-mediated neuronal transmission
  • Long-term potentiation
  • Non-syndromic X-linked mental retardation

Page 7 out of 36 pages